Willcaygill·Sep 2Extra Credit, Not Homework: How Teva Won $176.5 Million by Claiming Less Than Amgen DidWhat a migraine drug fight teaches about the line between a valid genus claim and an invalid one
InInsights by Dr. Rahul DevbyRahul Dev·Jan 20, 2016BioSpectrum Asia — Compulsory License of Bayer’s Nexavar
InInsights by Dr. Rahul DevbyRahul Dev·Jan 20, 2016Economic Times — Monsanto’s Climate Resilient Crop Patent Rejection
